Cargando…
Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: The effects of allopurinol in patients with cardiovascular disease are not well defined; therefore, the latest evidence is summarized in this study. Methods: PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched for randomized controlled trials (RCTs) of allopu...
Autores principales: | Ye, Yuyang, Liao, Guangzhi, Liu, Ting, Hu, Xinru, Chen, Xuefeng, Bai, Lin, Peng, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532321/ https://www.ncbi.nlm.nih.gov/pubmed/37754808 http://dx.doi.org/10.3390/jcdd10090379 |
Ejemplares similares
-
Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis
por: Liao, Guangzhi, et al.
Publicado: (2022) -
A meta-analysis of allopurinol therapy and the risk of prostate cancer
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Efficacy of Allopurinol in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Ullah, Waqas, et al.
Publicado: (2020) -
Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
por: Mansoor, Kanaan, et al.
Publicado: (2021) -
Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis
por: van der Pol, Karel H., et al.
Publicado: (2021)